Subcutaneous Alemtuzumab Combined With Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allo-SCT in CLL With 17p- or Refractory to Fludarabine
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Chronic Lymphocytic Leukemia
Related studies linked through entity extraction aliases.
Akt Inhibitor MK2206, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Unrelated Donor Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- NA
Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.
- Status
- COMPLETED
- Phase
- PHASE1
Combination of Pentostatin, Bendamustine and Ofatumumab for Treatment of Chronic Lymphocytic Leukemia and Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
- Status
- COMPLETED
- Phase
- PHASE1
Lenalidomide and Vaccine Therapy in Treating Patients With Early-Stage Asymptomatic Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative Donor
- Status
- COMPLETED
- Phase
- PHASE2
Genomic Analysis of Patients With Chronic Lymphocytic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ofatumumab Added to Dexamethasone in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation
- Status
- TERMINATED
- Phase
- PHASE1
AMG 319 Lymphoid Malignancy FIH
- Status
- COMPLETED
- Phase
- PHASE1
Low Dose CdA Combined With Valproic Acid (VPA) in Previously Treated B-cell Chronic Lymphocytic Leukemia(B-CLL)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study of Escalating Doses of Polatuzumab Vedotin in Participants With Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma and Chronic Lymphocytic Leukemia and Polatuzumab Vedotin in Combination With Rituximab in Participants With Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Blinded Cross-Over Bioequivalence (BE) Trial of Luitpold Azacitidine vs Vidaza
- Status
- COMPLETED
- Phase
- PHASE1
Nonmyeloablative Allogeneic Transplant
- Status
- COMPLETED
- Phase
- NA
Lenalidomide in Treating Patients With High-Risk Chronic Lymphocytic Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE2
Antiviral Treatment of Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE4